Atlas Trials

Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19

Clinical trial NCT05172180 · COMPLETED

Trial details

NCT number
NCT05172180
Sponsor
POLYSAN Scientific & Technological Pharmaceutical Company
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2020-12-01
Primary completion
2021-01-31
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.